Literature DB >> 28877981

Prospective study on the incidence, prevalence and 5-year pancreatic-related mortality of pancreatic cysts in a population-based study.

Marie-Luise Kromrey1, Robin Bülow1, Jenny Hübner1, Christin Paperlein1, Markus M Lerch2, Till Ittermann3, Henry Völzke3, Julia Mayerle2,4, Jens-Peter Kühn1,5.   

Abstract

OBJECTIVE: To analyse the prevalence, incidence and clinical relevance of pancreatic cysts detected as incidental finding in a population-based longitudinal study.
DESIGN: A total of 1077 participants (521 men, mean age 55.8±12.8 years) of 2333 participants from the population-based Study of Health in Pomerania (SHIP) underwent magnetic resonance cholangiopancreaticography (MRCP) at baseline (2008-2012). MRCP was analysed for pancreatic cysts with a diameter ≥2 mm. 676/1077 subjects received a 5-year follow-up (2014-2016). The prevalence and incidence of pancreatic cysts (weighted for study participation) were assessed in association to age, gender and suspected epidemiological risk factors. Mortality follow-up was performed in 2015 for all SHIP participants (mean follow-up period 5.9 years, range 3.2-7.5 years).
RESULTS: At baseline pancreatic cysts had a weighted prevalence of 49.1%, with an average number of 3.9 (95% CI 3.2 to 4.5) cysts per subject in the subgroup harbouring cysts. Cyst size ranged from 2 to 29 mm. Prevalence (p<0.001), number (p=0.001) and maximum size (p<0.001) increased significantly with age. The 5-year follow-up revealed a weighted incidence of 12.9% newly detected pancreatic cysts. 57.1% of the subjects initially harbouring pancreatic cysts showed an increase in number and/or maximum cyst size. Of all subjects undergoing MRCP, no participant died of pancreatic diseases within mortality follow-up.
CONCLUSION: The prevalence of pancreatic cysts in the general population is unexpectedly high, and their number and size increase with age. Overall, no pancreatic cancer was observed in this collective during a 5-year follow-up. Nevertheless, prospective follow-up imaging showed minimal progress in more than 50%. Only about 6% of cysts and 2.5% of the study group initially presented with cysts of more than 1 cm and thus might be clinically meaningful. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  magnetic resonance imaging; pancreas; pancreatic cancer; pancreatic epidemiology; pancreatic tumors

Mesh:

Year:  2017        PMID: 28877981     DOI: 10.1136/gutjnl-2016-313127

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  44 in total

1.  Clinical Impact of KRAS and GNAS Analysis Added to CEA and Cytology in Pancreatic Cystic Fluid Obtained by EUS-FNA.

Authors:  Sandra Faias; Marlene Duarte; Cristina Albuquerque; João Pereira da Silva; Ricardo Fonseca; Ruben Roque; Antonio Dias Pereira; Paula Chaves; Marília Cravo
Journal:  Dig Dis Sci       Date:  2018-05-24       Impact factor: 3.199

2.  [Pancreatic disorders : What is new?]

Authors:  J Mössner; M M Lerch
Journal:  Internist (Berl)       Date:  2019-03       Impact factor: 0.743

3.  New light on the pancreatic cyst conundrum.

Authors:  Nathan A Berger
Journal:  Transl Cancer Res       Date:  2018-06       Impact factor: 1.241

Review 4.  Pancreatic cystic neoplasms: a review of current recommendations for surveillance and management.

Authors:  Justin G Yoon; Daniel Smith; Vijayanadh Ojili; Raj Mohan Paspulati; Nikhil H Ramaiya; Sree Harsha Tirumani
Journal:  Abdom Radiol (NY)       Date:  2021-03-20

Review 5.  Early Detection of Pancreatic Cancer: Opportunities and Challenges.

Authors:  Aatur D Singhi; Eugene J Koay; Suresh T Chari; Anirban Maitra
Journal:  Gastroenterology       Date:  2019-02-02       Impact factor: 22.682

Review 6.  Management Algorithm for Cystic Pancreatic Lesions.

Authors:  Georg Beyer; Elisabetta Goni; Marlies Köpke; Jan G D'Haese; Jens Werner; Jörg Schirra; Julia Mayerle
Journal:  Visc Med       Date:  2018-06-13

7.  Recent Trends in the Incidence and Survival of Stage 1A Pancreatic Cancer: A Surveillance, Epidemiology, and End Results Analysis.

Authors:  Amanda L Blackford; Marcia Irene Canto; Alison P Klein; Ralph H Hruban; Michael Goggins
Journal:  J Natl Cancer Inst       Date:  2020-11-01       Impact factor: 13.506

8.  Risk of malignancy in small pancreatic cysts decreases over time.

Authors:  D Ciprani; M Weniger; M Qadan; T Hank; N K Horick; J M Harrison; G Marchegiani; S Andrianello; P V Pandharipande; C R Ferrone; K D Lillemoe; A L Warshaw; C Bassi; R Salvia; C Fernández-Del Castillo
Journal:  Pancreatology       Date:  2020-08-10       Impact factor: 3.996

9.  Abdominal Imaging of Pancreatic Cysts and Cyst-Associated Pancreatic Cancer in BRCA1/2 Mutation Carriers: A Retrospective Cross-Sectional Study.

Authors:  Carrie X Cao; Jeremy M Sharib; Amie M Blanco; Dena Goldberg; Paige Bracci; Rita A Mukhtar; Laura J Esserman; Kimberly S Kirkwood
Journal:  J Am Coll Surg       Date:  2019-10-28       Impact factor: 6.113

10.  Extracellular Vesicle Analysis Allows for Identification of Invasive IPMN.

Authors:  Katherine S Yang; Debora Ciprani; Aileen O'Shea; Andrew S Liss; Robert Yang; Sarah Fletcher-Mercaldo; Mari Mino-Kenudson; Carlos Fernández-Del Castillo; Ralph Weissleder
Journal:  Gastroenterology       Date:  2020-12-07       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.